Improvement of Long-Term Outcomes in Hepatitis C Virus Antibody–Positive Patients with Hepatocellular Carcinoma after Hepatectomy in the Modern Era
✍ Scribed by Ken Shirabe; Kazuki Takeishi; Akinobu Taketomi; Hideaki Uchiyama; Hiroto Kayashima; Yoshihiko Maehara
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 257 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have cloned the whole structural region of the hepatitis C virus (HCV) genome and transiently expressed the nucleocapsid protein in animal cells. Since the nucleotide sequences of this region of the HCV genome has been shown to be highly conserved among different HCV isolates, the assay detecting
In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for
## It is well known that hepatitis C virus (HCV) infection may progress to cirrhosis and is linked to the development of hepatocellular carcinoma (HCC). Previous studies have shown that compensated HCV-cirrhosis is related to a certain morbidity and mortality in European patients, but little is kn